.png?width=700&name=New-ATE-Logo2019%20(1).png)
Advanced Technology for Vector-Based
Therapies Highlighting Stem Cell-Derived
Exosomes Manufacturing Process
Presenters:
Elie Zakhem is the senior manager of process development at RoosterBio. In his current role, Elie leads the efforts to develop scalable processes for manufacturing MSCs and MSC-derived extracellular vesicles including the tech transfer part. Prior to joining RoosterBio, Elie was a senior scientist at ACell (now Integra LifeSciences) where his work focused on developing, optimizing, and characterizing extracellular matrix-based materials for regenerative medicine purposes. Elie graduated with a doctoral degree in molecular medicine and translational sciences from Wake Forest University with a focus on tissue engineering. He also has a master’s degree in biomedical engineering from Wayne State University. Elie has over 12 years of experience in the field of regenerative medicine
Jeremy Neidert performed this work and supported RoosterBio as a field application scientist with Repligen. After completing his bachelor's degree in biomedical engineering from Widener University, Jeremy began his career in biopharmaceutical processing at GSK where he worked in process development and large scale GMP manufacturing. He then moved to Ajinomoto, a CDMO, where he continued to focus on tech transfer and commercial manufacturing processes. This experience allows Jeremy to successfully assist and guide many customers to develop and implement upstream and downstream bioprocesses across a range of applications as a field application scientist at Repligen Corporation.
Click the link below to view the Dare to Innovate: Across the Bioprocess Workflow series page.
